|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
23
|
|
pubmed:dateCreated |
1998-7-2
|
|
pubmed:abstractText |
Atrial fibrillation (AF) has been shown to shorten the atrial effective refractory period (ERP) and make the atrium more vulnerable to AF. This study investigated the effect of atrial rate and antiarrhythmic drugs on ERP shortening induced by tachycardia.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0009-7322
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
16
|
|
pubmed:volume |
97
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2331-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9639377-Adult,
pubmed-meshheading:9639377-Aged,
pubmed-meshheading:9639377-Amiodarone,
pubmed-meshheading:9639377-Anti-Arrhythmia Agents,
pubmed-meshheading:9639377-Atrial Fibrillation,
pubmed-meshheading:9639377-Electrocardiography,
pubmed-meshheading:9639377-Electrophysiology,
pubmed-meshheading:9639377-Female,
pubmed-meshheading:9639377-Humans,
pubmed-meshheading:9639377-Male,
pubmed-meshheading:9639377-Middle Aged,
pubmed-meshheading:9639377-Pacemaker, Artificial,
pubmed-meshheading:9639377-Procainamide,
pubmed-meshheading:9639377-Propafenone,
pubmed-meshheading:9639377-Propranolol,
pubmed-meshheading:9639377-Sotalol,
pubmed-meshheading:9639377-Tachycardia, Supraventricular,
pubmed-meshheading:9639377-Verapamil
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs.
|
|
pubmed:affiliation |
Department of Medicine, Veterans General Hospital-Taipei, Taiwan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
